No abstract available
MeSH terms
-
Administration, Oral
-
Animals
-
Chemokine CXCL1 / genetics
-
Chemokine CXCL1 / immunology
-
Drug Administration Schedule
-
Female
-
Gene Expression Regulation
-
Granulocyte Colony-Stimulating Factor / genetics
-
Granulocyte Colony-Stimulating Factor / immunology
-
Granulocyte-Macrophage Colony-Stimulating Factor / genetics
-
Granulocyte-Macrophage Colony-Stimulating Factor / immunology
-
Immunity, Innate / drug effects
-
Interferon-gamma / genetics
-
Interferon-gamma / immunology
-
Interleukin-6 / genetics
-
Interleukin-6 / immunology
-
Interleukin-8 / agonists
-
Interleukin-8 / genetics
-
Interleukin-8 / immunology*
-
Leukocyte Count
-
Macaca fascicularis
-
Male
-
Neutrophils / cytology
-
Neutrophils / drug effects*
-
Neutrophils / immunology
-
Phagocytosis / drug effects*
-
Pyrimidines / pharmacology*
-
Receptors, Interleukin-8B / antagonists & inhibitors
-
Receptors, Interleukin-8B / genetics
-
Receptors, Interleukin-8B / immunology*
-
Respiratory Burst / drug effects*
-
Signal Transduction
-
Sulfonamides / pharmacology*
-
Toxicity Tests, Chronic
-
Tumor Necrosis Factor-alpha / genetics
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Chemokine CXCL1
-
Interleukin-6
-
Interleukin-8
-
N-(2-(2,3-difluoro-6-benzylthio)-6-(3,4-dihydroxybutan-2-yloxy)pyrimidin-4-yl)azetidine-1-sulfonamide
-
Pyrimidines
-
Receptors, Interleukin-8B
-
Sulfonamides
-
Tumor Necrosis Factor-alpha
-
Granulocyte Colony-Stimulating Factor
-
Interferon-gamma
-
Granulocyte-Macrophage Colony-Stimulating Factor